Brief: Cara Therapeutics Announces 1-For-3 Reverse Stock Split
April 14 (Reuters) - Cara Therapeutics Inc CARA.O: CARA THERAPEUTICS ANNOUNCES 1-FOR-3 REVERSE STOCK SPLIT IN CONNECTION WITH THE PROPOSED MERGER WITH TVARDI THERAPEUTICS Source text: ID:nGNX8kfqG2 Further company coverage: CARA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tvardi Therapeutics
See all newsTvardi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tvardi Therapeutics Q2 net loss slightly lower estimates
Brief: Tvardi Therapeutics Inc Q2 Net Income USD -6.5 Million Vs. IBES Estimate USD -6.54 Million
Tvardi Therapeutics, Inc. expected to post a loss of 70 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:50 PM